1Schlant RC, Forman S, Stamler J, et al. The natural history of coronary heart disease : prognostic factors after recovery from myocardial infarction in 2789 men.The 52year findings of the coronary drug project[J].Circulation, 1982,66:4012 - 414.
3Siess W. Athero-and thrombogenic actions of lysophosphati- dic acid and sphingosine-1-phosphate[J]. Biochim Biophys Acta,2002,1582:204.
4Siess W, Zangl KJ, EsslerM, et al. Lysophosphatidic acid mediates the rapid activation of platelets and endothelial cells by mildly oxidized low density lipoprotein and accumulates in human atherosclerotic lesions[J],Pine Natl Acad Sci USA,1999,96:6931.
5MoolenaarWH. Development of our current understanding ofbioactive lysophospholipids[J]. A nn N Y A cad Sci ,2000,905(4): 1.
7Qu XF,Song Y,Li JJ,et al.The relationship between the levels of lysophosphatidic acid and left ventricular remodeling after acute myocardial infarction [J]. Zhonghua Yi Xue Za Zhi(中文版),2004,84(12):1005.
9F ranz2Jo set N eumannMD,Ilka O ttMD,M einrad GawazMD,et al.Cardiac release of cytok ines and inflammato ry responses in a2 cute myocardial infarction[J].Circulation,1995,92(4) :748.
5Torti M, Tolnai E, Beltoni A, et al. Activation of human platelets by lysophosphatidic acid[J]. Blood Coagul Fibrinolysis, 1996,7:253-255.
6Gueguen G, Gaige B, Grevy JM, et al. Structure-activity analysis of the effects of lysophosphatidic acid on platelet aggregation [ J ]. Biochemistry, 1999,38:8400-8450.
